catalog number :
MBS669029
products full name :
Monoclonal Antibody to Spectrin beta 3 (Clone: ABM5A16)
products short name :
[Spectrin beta 3]
products name syn :
[Spectrin beta chain; non-erythrocytic 2; Beta-III spectrin; Spinocerebellar ataxia 5 protein]
other names :
[spectrin beta chain, non-erythrocytic 2; Spectrin beta chain, non-erythrocytic 2; spectrin beta chain, non-erythrocytic 2; spectrin beta, non-erythrocytic 2; Beta-III spectrin; Spinocerebellar ataxia 5 protein]
products gene name :
[SPTBN2]
other gene names :
[SPTBN2; SPTBN2; SCA5; SCAR14; GTRAP41; KIAA0302; SCA5]
purity :
Purified. Protein G Chromatography
form :
Purified. 25 ug in 50 uL/100 ug in 200 uL in PBS containing 0.05%BSA and 0.05% sodium azide. Sodium azide is highly toxic.
storage stability :
Store the antibody at 4°C; stable for 6 months. For long-term storage; store at -20°C. Avoid repeated freeze and thaw cycles.
tested application :
Western Blot (WB), Flow Cytometry (FC/FACS)
app notes :
WB: 0.1-0.5 ug/ml. FACS: 2-4 ug/10 6
image1 heading :
Western Blot (WB)
image2 heading :
Flow Cytometry (FC/FACS)
image3 heading :
Flow Cytometry (FC/FACS)
other info1 :
Immunogen : A partial length recombinant protein (a.a 1280-1450) of Spectrin beta 3 was used as the immunogen for this antibody.
products categories :
Cancer Marker
products description :
Beta-III spectrin is a protein encoded by the gene SPTBN2, spans 2390 amino acids and consists of an amino-terminal actin binding domain (ABD), a central region containing seventeen spectrin repeat domains, and a carboxy-terminal pleckstrin homology domain. It is critical for the correct development and maintenance of Purkinje cell dendritic structure. Beta-III spectrin is expressed predominantly in the brain and is enriched in cerebellar Purkinje cells. In addition, Beta-III spectrin participates in endomembrane trafficking through its interaction with the actin related protein, ARP1. The functional unit of Beta-III spectrin is considered to be a tetrameric complex composed of two Beta-spectrin subunits and two Alpha-II-spectrin subunits. Mutations in the gene encoding Beta-III spectrin give rise to spinocerebellar ataxia type 5, a neurodegenerative disease characterized by progressive thinning of the molecular layer, loss of Purkinje cells and increasing motor deficits.
ncbi acc num :
NP_008877.1
ncbi gb acc num :
NM_006946.3
ncbi mol weight :
268,309 Da
ncbi pathways :
Axon Guidance Pathway (575211); Axon Guidance Pathway (105688); Developmental Biology Pathway (575210); Developmental Biology Pathway (477129); Interaction Between L1 And Ankyrins Pathway (161005); L1CAM Interactions Pathway (161003); NCAM Signaling For Neurite Out-growth Pathway (105689); NCAM Signaling For Neurite Out-growth Pathway (575220)
ncbi summary :
Spectrins are principle components of a cell's membrane-cytoskeleton and are composed of two alpha and two beta spectrin subunits. The protein encoded by this gene (SPTBN2), is called spectrin beta non-erythrocytic 2 or beta-III spectrin. It is related to, but distinct from, the beta-II spectrin gene which is also known as spectrin beta non-erythrocytic 1 (SPTBN1). SPTBN2 regulates the glutamate signaling pathway by stabilizing the glutamate transporter EAAT4 at the surface of the plasma membrane. Mutations in this gene cause a form of spinocerebellar ataxia, SCA5, that is characterized by neurodegeneration, progressive locomotor incoordination, dysarthria, and uncoordinated eye movements. [provided by RefSeq, Dec 2009]
uniprot summary :
Probably plays an important role in neuronal membrane skeleton.